Wednesday, May 1, 2019

United Therapeutics reports Q1 EPS $3.58, consensus $2.78

Reports Q1 revenue $362.6M, consensus $335.43M.
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.